{"id":"https://openalex.org/W2600964397","doi":"https://doi.org/10.1016/j.therap.2017.01.012","title":"Effets psychoactifs des \u00ab legal high \u00bb : \u00e0 propos de l\u2019acide lysergique amide (LSA)","display_name":"Effets psychoactifs des \u00ab legal high \u00bb : \u00e0 propos de l\u2019acide lysergique amide (LSA)","publication_year":2017,"publication_date":"2017-03-30","ids":{"openalex":"https://openalex.org/W2600964397","doi":"https://doi.org/10.1016/j.therap.2017.01.012","mag":"2600964397","pmid":"https://pubmed.ncbi.nlm.nih.gov/28457570"},"language":"fr","primary_location":{"id":"doi:10.1016/j.therap.2017.01.012","doi":"https://doi.org/10.1016/j.therap.2017.01.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.therap.2017.01.012","pdf_url":null,"source":{"id":"https://openalex.org/S102552068","display_name":"Therapies","issn_l":"0040-5957","issn":["0040-5957","1958-5578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002315092","display_name":"Camille Pont\u00e9","orcid":"https://orcid.org/0000-0001-8616-5313","observed_orcids":["https://orcid.org/0000-0001-8616-5313"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Camille Pont\u00e9","raw_affiliation_strings":["Service de pharmacologie m\u00e9dicale et clinique, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance-addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France. Electronic address: ponte.c@chu-toulouse.fr","Service de pharmacologie m\u00e9dicale et clinique, Centre d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance\u2013addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de pharmacologie m\u00e9dicale et clinique, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance-addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France. Electronic address: ponte.c@chu-toulouse.fr","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de pharmacologie m\u00e9dicale et clinique, Centre d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance\u2013addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050870063","display_name":"Maryse Lapeyre\u2010Mestre","orcid":"https://orcid.org/0000-0002-5494-5873","observed_orcids":["https://orcid.org/0000-0002-5494-5873"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maryse Lapeyre-Mestre","raw_affiliation_strings":["Service de pharmacologie m\u00e9dicale et clinique, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance-addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de pharmacologie m\u00e9dicale et clinique, Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance-addictovigilance, facult\u00e9 de m\u00e9decine, CHU de Toulouse, 37, all\u00e9es Jules-Guesde, 31000 Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002315092"],"corresponding_institution_ids":["https://openalex.org/I3019448017"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":null,"fwci":0.6068,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.71704115,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"72","issue":"5","first_page":"605","last_page":"608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.5791000127792358,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.5791000127792358,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.40059998631477356,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysergic-acid-amide","display_name":"lysergic acid amide","score":0.9850000143051147},{"id":"https://openalex.org/keywords/new-psychoactive-substances","display_name":"new psychoactive substances","score":0.75},{"id":"https://openalex.org/keywords/psychedelics","display_name":"psychedelics","score":0.6159999966621399},{"id":"https://openalex.org/keywords/hallucinogenic-effects","display_name":"hallucinogenic effects","score":0.7599999904632568},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5720000267028809},{"id":"https://openalex.org/keywords/drug-poisoning","display_name":"drug poisoning","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C3019607171","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychoactive substance","level":2,"score":0.6152607798576355},{"id":"https://openalex.org/C2991912374","wikidata":"https://www.wikidata.org/wiki/Q400711","display_name":"Substance use","level":2,"score":0.5698631405830383},{"id":"https://openalex.org/C2780456611","wikidata":"https://www.wikidata.org/wiki/Q2917466","display_name":"Psychic","level":3,"score":0.4798119068145752},{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.4028676152229309},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.3345915675163269},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.22394639253616333},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2168618142604828},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1635897159576416},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.therap.2017.01.012","doi":"https://doi.org/10.1016/j.therap.2017.01.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.therap.2017.01.012","pdf_url":null,"source":{"id":"https://openalex.org/S102552068","display_name":"Therapies","issn_l":"0040-5957","issn":["0040-5957","1958-5578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapies","raw_type":"journal-article"},{"id":"pmid:28457570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28457570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapie","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W164213004","https://openalex.org/W1990456617","https://openalex.org/W2026502866","https://openalex.org/W2082806458","https://openalex.org/W2115931889","https://openalex.org/W2129576528","https://openalex.org/W2160700802","https://openalex.org/W2169847425","https://openalex.org/W2397297965","https://openalex.org/W2404165333","https://openalex.org/W2552761136"],"related_works":["https://openalex.org/W2592417296","https://openalex.org/W4412526435","https://openalex.org/W4401925482","https://openalex.org/W7135165201","https://openalex.org/W4401478545","https://openalex.org/W2051117127","https://openalex.org/W2410741250","https://openalex.org/W2409096813","https://openalex.org/W2418350283","https://openalex.org/W2129576528"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-04-07T00:00:00"}